b Department of Statistics
|
|
- Lambert Blake
- 5 years ago
- Views:
Transcription
1 A Comparison of Anesthetic and Cardiorespiratory Effects of Tiletamine Zolazepam Butorphanol and Tiletamine Zolazepam Butorphanol Medetomidine in Cats Jeff C. H. Ko, DVM, MS, DACVA a Lisa A. Abbo, DVM a Ann B. Weil, MS, DVM, DACVA a Brenda M. Johnson, BS, RVT a Mark Payton, PhD b a Department of Veterinary Clinical Sciences School of Veterinary Medicine Purdue University West Lafayette, IN 4797 b Department of Statistics College of Arts and Sciences Oklahoma State University Stillwater, OK 7478 CLI NI CA L RE L E VA N C E Using a randomized crossover design, this study compared the anesthetic and cardiorespiratory effects of three intramuscular anesthetic combinations in seven 2- year-old cats: tiletamine zolazepam (8 mg/kg) and butorphanol (.2 mg/kg) (TT); tiletamine zolazepam (3 mg/kg), butorphanol (.15 mg/kg), and medetomidine (15 µg/kg) (TTD); or the TTD protocol plus atipamezole (75 µg/kg IM) given 2 minutes later to reverse medetomidine. Analgesia was assessed using algometry and needle pricking. All three combinations effectively induced anesthesia suitable for orotracheal intubation within 5 minutes after injection. Hemoglobin oxygen saturation was lower than 9% at least once in all three groups between 5 and 15 minutes after drug administration. Blood pressure and heart and respiratory rates were within normal ranges. Both TT and TTD appeared to be effective injectable anesthetic combinations. TTD provided significantly better analgesia with a longer duration than did TT. Atipamezole administration shortened the duration of analgesia and decreased blood pressure but did not shorten total recovery time. INTRODUCTION Tiletamine zolazepam has been used alone or in combination with other anesthetic agents in cats. 1 8 One particular combination, tiletamine This project was funded by a research grant from Fort Dodge Animal Health, Overland Park, Kansas. zolazepam, ketamine, and xylazine, has been widely used in cats since its introduction in With the advancement of α 2 agonist development, xylazine is less commonly used in small animals today and has gradually been replaced by medetomidine. In a study in cats, 9 the 16
2 J. C. H. Ko, L. A. Abbo, A. B. Weil, B. M. Johnson, and M. Payton MATERIALS AND METHODS This study was approved by the Purdue University Animal Care and Use Committee. Seven 2-year-old cats (three females and four males; mean body weight: 6.2 ± 1.1 kg) were used in this randomized, crossover study, with each cat receiving three IM drug combinations: TT: Tiletamine zolazepam (Telazol, Fort Dodge Animal Health; 8 mg/kg) and butorphanol (Torbugesic, Fort Dodge Animal Health;.2 mg/kg) TTD: Tiletamine zolazepam (3 mg/kg), butorphanol (.15 mg/kg), and medetomidine (Domitor, Pfizer Animal Health; 15 µg/kg) TTDA: Tiletamine zolazepam (3 mg/kg), butorphanol (.15 mg/kg), and medetomidine (15 µg/kg) followed by atipamezole (Antisedan, Pfizer Animal Health; 75 µg/kg IM) 2 minutes after TTD administration to reverse medetomidine All three anesthetic combinations rapidly induced sedation anesthesia and lateral recumbency within 3 minutes after administration. combination of medetomidine (8 µg/kg) and ketamine (5 mg/kg) was compared with either tiletamine zolazepam (15 mg/kg) or xylazine (1 mg/kg) and ketamine (1 mg/kg) for ovariohysterectomy; the authors concluded that the medetomidine ketamine combination provided better muscle relaxation and analgesia compared with the other two drug combinations. In another study in cats, 5 a combination of tiletamine zolazepam and butorphanol used for onychectomy was found to prevent epinephrine release for 2 hours and to provide adequate analgesia. The anesthetic and analgesic effects of tiletamine zolazepam in combination with butorphanol and medetomidine is currently unreported in cats. The objectives of this study were to evaluate and compare the anesthetic and cardiorespiratory effects of tiletamine zolazepam butorphanol (TT [Telazol Torbugesic]) and tiletamine zolazepam butorphanol medetomidine (TTD [Telazol Torbugesic Domitor]) in cats. It was hypothesized that TTD would have a longer duration of anesthesia and provide a better quality of analgesia than TT. It was further hypothesized that using atipamezole to reverse medetomidine in the TTD combination would decrease recovery time. Atipamezole was given 2 minutes after TTD administration to allow the residual effects of tiletamine and zolazepam during recovery to be assessed. It was hypothesized that the use of atipamezole 2 minutes after administration of TTD would shorten recovery time without affecting recovery quality; however, medetomidine reversal was expected to negatively affect the quality of analgesia in cats. Lower doses of tiletamine zolazepam and butorphanol were used in the TTD and TTDA groups because of the anticipated augmentation of sedation and analgesia by medetomidine. All drugs were drawn up separately and administered together as a single IM injection. All cats breathed room air throughout each study period. Body temperatures were maintained between 99.9 F and 11.2 F with two water-circulating heating blankets and towels. The washout period between treatments was 2 to 3 weeks. Time from IM injection to lateral recumbency, orotracheal intubation, recovery, sternal 165
3 TABLE 1. Central Nervous System Depression and Recovery Scoring System Used to Evaluate Cats Score Description Sedation Anesthesia 1 Reduced activity only 2 Mild sedation: mildly aware of the surrounding environment 3 Moderate sedation: eyes droopy, head down, inactive, sternal recumbency, unable to be intubated Recovery Profound sedation anesthesia: no movement, rapid assumption of lateral recumbency with great muscle relaxation and easy intubation 1 Prolonged struggling, unable to stand without assistance, hyperkinesis in response to manual assistance, increased rectal temperature associated with increased struggling resulting in increased metabolism 2 Some struggling, repeated attempts to stand, assistance required to stand, significant instability and inability to maintain balance while walking, some signs of drug hangover 3 Some struggling, some assistance required to stand, ability to maintain balance once standing, minimal signs of drug hangover Resumption of sternal recumbency with minimal struggling, ability to stand and walk with minimal effort, no signs of drug hangover recumbency, and standing and walking (i.e., not just standing and falling back into sternal recumbency) were recorded. Overall quality of sedation anesthesia was scored, as was quality of recovery (Table 1). Orotracheal intubation was achieved without the aid of topical lidocaine application. A semi-rigid polypropylene urinary catheter (1 Fr; Kendall, Mansfield, MA) was used as a stylet. After the stylet was placed in the laryngeal opening, the endotracheal tube was passed through the stylet coaxially. For each study period, baseline heart rate (HR), respiratory rate (RR), indirect systolic arterial blood pressure (SAP), indirect diastolic arterial blood pressure (DAP), indirect mean arterial blood pressure (MAP), and rectal temperature were measured immediately before drug administration. After baseline data (time ) were collected, cats were immediately given the IM drug combination; SAP, DAP, MAP, HR, RR, and electrocardiographic (ECG) rhythm were then recorded at 5- minute intervals until the cat had recovered to sternal recumbency. End-tidal carbon dioxide (ETCO 2 ) was measured using a sidestream capnograph (Passport, Gas Module, Datascope, Mahwah, NJ) with a 5-Fr rubber urinary catheter (Kendall) inserted coaxially into the endotracheal tube until the tip rested in the thoracic inlet; capnographic measurements started immediately after orotracheal intubation and continued until the cat was extubated. Two methods were used to assess analgesia: algometry and pin prick. The use of an algometer for determination of pain thresholds for pressure application in soft tissue, muscles, and joints has been demonstrated in humans 1 and horses. 11 The algometer used in this study (Somedic Algometer type, Somedic Production AB, Stockholm, Sweden) is equipped with a squeeze handle; when the handle is squeezed, two nontraumatizing sensors exert a noxious pressure (expressed in kilopascals [kpa]; device range: to 2, kpa) on the tissue of the patient being evaluated. Before each study, the 166
4 Systolic Blood Pressure (mm Hg) Overall, Blood Pressure Was Well Maintained in All Groups Time (min) Mean Blood Pressure (mm Hg) Diastolic Blood Pressure (mm Hg) Time (min) Time (min) TT TTD TTDA Figure 1. Blood pressure values after IM administration of tiletamine zolazepam butorphanol (TT), tiletamine zolazepam butorphanol medetomidine (TTD), and tiletamine zolazepam butorphanol medetomidine reversed with atipamezole (TTDA) in seven cats. All data are presented as mean ± SEM. Significantly different from other treatment groups. Significantly different from the TTDA group. Significantly different from the TT group. Significantly different from baseline within the treatment group. Significantly different from the 2-minute value within treatment group. 167
5 algometer was calibrated against a weight to ensure its accuracy. The algometer was applied to a front digit after the cat was anesthetized. As soon as the cat exhibited a sign of pain, including withdrawal of a limb, head lift, or other purposeful movement related to this noxious stimulus, the algometer was released and the pressure recorded. A pin prick with a 22-gauge hypodermic needle was the second method used to assess analgesia. The sequence of needle pricking was front limb along the radial ulnar area followed by the perineal area near the base of the tail. Any gross purposeful movement of the limb or body or constriction of the anus in reaction to the needle pricking was interpreted as lack of analgesia, and the duration of analgesia was recorded. treatments for given time intervals were presented if the overall effect of treatment was significant using a SLICE option in an LSMEANS statement (PROC MIXED). All results are reported as mean ± SEM. RESULTS All three combinations rapidly induced sedation anesthesia and lateral recumbency within 3 minutes after administration (Table 2). No vomiting, myoclonic twitching responses, or other adverse reactions were observed in the time between injection and orotracheal intubation. All cats were intubated with ease within 5 minutes after drug administration, and no laryngeal complications were noted during intubation or recovery despite the fact that the larynx was not desensitized All cats were intubated with ease within 5 minutes after drug administration. Analgesia evaluations occurred immediately after each cardiorespiratory evaluation. All analgesia evaluations occurred in the same order (algometer, then needle prick) at each time point. Statistical Analysis PC SAS (SAS Institute, Cary, NC) was used for all statistical analyses. Analysis of variance techniques (PROC MIXED in SAS, Version 9) were used to assess treatment differences in anesthesia, analgesia, and cardiorespiratory data. When multiple observations were made on the same subject over time, repeated measures models were used with an autoregressive period 1 covariance structure to account for within-subject correlations. Effects of treatments were presented as pairwise t-tests when a significant difference (P <.5) was detected in the analysis of variance. In the case of the repeated measures analyses, simple effects of with lidocaine. There was no significant difference among the three treatment groups in onset of sedation and time from injection to lateral recumbency and intubation. However, the duration of intubation tolerance was significantly shorter in the TTDA group compared with the TTD group. The duration of lateral recumbency, time from injection to resumption of sternal recumbency, and time to resumption of standing and walking were not significantly different between treatment groups (Table 2). The quality of recovery score was significantly lower in the TTDA group than in the TTD group. Baseline SAP, MAP, and DAP were not significantly different between treatment groups. In the TT group, SAP was significantly different from baseline at 5 minutes and DAP was significantly different from baseline at 15 minutes (Figure 1). Overall, blood pressure was 168
6 J. C. H. Ko, L. A. Abbo, A. B. Weil, B. M. Johnson, and M. Payton TABLE 2. Sedation Anesthesia Variables after IM Administration of Tiletamine Zolazepam Butorphanol (TT), Tiletamine Zolazepam Butorphanol Medetomidine (TTD), and Tiletamine Zolazepam Butorphanol Medetomidine Reversed with Atipamezole (TTDA) in Seven Cats Treatment Variable TT (n = 7) TTD (n = 7) TTDA (n = 7) Time from injection to onset of sedation (min) 1.22 ± ± ±.17 Time from injection to sternal recumbency (min) 1.7 ± ± ±.18 Time from injection to lateral recumbency (min) 1.89 ± ± ±.2 Time from injection to orotracheal intubation (min) 3.36 ± ±. 3.6 ±.51 Duration of intubation (min) ± 5.8 a,b ±.83 a 6.86 ± 6.5 b Duration of lateral recumbency (min) 16.1 ± ± ± 18.6 Time from injection to resumption of ± ± ± sternal recumbency (min) Time from injection to standing and walking (min) ± ± ± 17.8 Overall quality of sedation 3.95 ±.1. ±.. ±. Overall quality of recovery 2.63 ±.2 a,b 3.7 ±.28 a 2.7 ±.17 b Data presented as mean ± SEM. A row without superscripts indicates no significant difference between treatment groups. Different superscripts within a row indicate a significant difference between treatment groups (P.5). See Table 1 for scoring system to evaluate sedation and recovery. well maintained, with the lowest MAP of 8.1 ± 6.7 mm Hg occurring 35 minutes after TT administration. There was no significant change in SAP after drug administration in either the TTD or TTDA group. DAP and MAP were higher in the TTD and TTDA groups compared with the TT group after 15 and 2 minutes, respectively. After these times, there was no significant difference between treatment groups. MAP was higher in the TTD group than in the TTDA group at 25 and 3 minutes after drug administration. Atipamezole administration resulted in a significant decrease in DAP (from 17.7 ± 12.6 mm Hg to 58. ± 3. mm Hg) in the TTDA-treated cats 5 minutes after injection. A significantly lower DAP was observed in the TTDA group compared with the TTD group between 25 and 5 minutes (Figure 1). Similarly, atipamezole administration resulted in a lower MAP in the TTDA group than in the TTD group at 25 and 3 minutes (Figure 1). Baseline HR was significantly higher in the TT group than the TTDA group. There was no significant change in HR after drug administration in the TT and TTDA groups over time. HR in the TT group was significantly higher than in the other groups at most time points; however, HR in the TTD group decreased significantly from the baseline rate of 17. ± 6.5 bpm to the lowest mean rate of 125. ±.3 bpm 6 minutes after drug administration (Figure 2). HRs in all three treatment groups were maintained above 125 bpm. 169
7 25 Heart Rates Remained Above 125 bpm in All Three Groups Heart Rate (bpm) Respiratory Rate (breaths/min) Time (min) Respiratory Rates Decreased 5 Minutes After Drug Administration in All Three Groups Time (min) TT TTD TTDA Figure 2. Cardiorespiratory values after IM administration of tiletamine zolazepam butorphanol (TT), tiletamine zolazepam butorphanol medetomidine (TTD), and tiletamine zolazepam butorphanol medetomidine reversed with atipamezole (TTDA) in seven cats. All data are presented as mean ± SEM. Significantly different from other treatment groups. Significantly different from the TTDA group. Significantly different from the TT group. Significantly different from baseline within the treatment group. The ECG of one cat in the TT group displayed a ventricular bigeminy rhythm 8 minutes after TT administration. The arrhythmia subsided within a few seconds and did not return, and the cat recovered from anesthesia uneventfully. By 5 minutes after drug administration and continuing through the end of the experiment, RRs decreased significantly from baseline in all three treatment groups. RRs were significantly higher in the TTD group at 3 minutes, but values were not significantly different ETCO 2 17
8 J. C. H. Ko, L. A. Abbo, A. B. Weil, B. M. Johnson, and M. Payton TABLE 3. Effects of Anesthesia on End-Tidal Carbon Dioxide (ETCO 2 ) and Hemoglobin Oxygen Saturation as Measured by Pulse Oximetry (SpO 2 ) in cats (n = 7) Tiletamine Tiletamine Tiletamine Zolazepam Zolazepam Butorphanol Time Zolazepam Butorphanol Butorphanol Medetomidine Medetomidine Atipamezole (min) ETCO 2 SpO 2 ETCO 2 SpO 2 ETCO 2 SpO 2 NA 98. ±. a NA 99.1 ±.3 a NA 98.9 ±. a ± ± 3.1 b 2.9 ± ± 6.5 e.3 ± ± 2.5 a 1 5. ± ±.3 b. ± ±. d,e 7.3 ± ± 1.9 a ± ±.6 b 3.7 ± ± 2.8 c,d,e 8.9 ± ± 2.5 a ± ± 2.1 a. ± ± 1.9 b,c,d,e 9.6 ± ± 2.2 a ± ±.9 a 5.3 ± ± 2.3 b,c,d,e 8.6 ± ± 1. a 3 5. ± ± 1.3 a.3 ±. 9.9 ± 1.8 a,b,c,d 9. ± ±.8 a ± ±.9 a 7. ± ± 1.7 b,c,d,e 6.9 ± ±.8 a 8.7 ± ± 1.3 a. ± ± 1.7 b,c,d,e 6.1 ± ± 1.1 a ± ±.8 a 8.6 ± ± 1.3 a,b,c,d,e.3 ± ± 1.2 a ± ± 1.2 a 3.7 ± ± 1.2 a,b,c,d 5. ± ±.3 a ± ±.9 a 6.6 ± ± 1.5 a,b,c,d. ± ± 1.2 a ± ± 1. a. ± ± 1.3 a,b,c,d 2.8 ± ± 1. a 65.6 ± ±.8 a 5.6 ± ±.7 a,b,c.3 ± ±.7 a ± ±.7 a 1.5 ± ±.7 a,b 5. ±. 99. ± 1. a ± ±. a. ± ± 1.5 a,b,c,d.5 ± ±.5 a 8 5. ±. 1. ±. a.3 ± ± 1.9 a,b,c,d 3.5 ± ± 1. a There were no significant differences in ETCO 2 and SpO 2 between treatment groups at each time point. a,b,c,d,e Values with different letters in a given column are significantly different. NA = not applicable. between treatment groups throughout the experiment (Figure 2 and Table 3). At least one SpO 2 (hemoglobin oxygen saturation as measured by pulse oximetry) reading of less than 9% was observed in the initial 1 minutes after administration of TTD and TTDA and in the initial 15 minutes after administration of TT. Thereafter, SpO 2 readings were consistently higher than 9% throughout the study (Table 3). Body temperatures were well maintained in the cats and were not significantly different between treatment groups throughout the study. Atipamezole administration at 2 minutes in the TTDA group did not significantly change HRs and RRs (Figure 2) or ETCO 2 concentrations (Table 3); however, significant reductions in DAP and MAP compared with values at 2 minutes (i.e., when atipamezole was administered) were noted in this group be- 171
9 Algometric Pressure Digit (kpa) 2, 1,8 1,6 1,4 1,2 1, No Differences in Tolerance to Pressure Were Noted in the First 45 Minutes Time (min) TT TTD TTDA Figure 3. Analgesia evaluation via algometer after IM administration of tiletamine zolazepam butorphanol (TT), tiletamine zolazepam butorphanol medetomidine (TTD), and tiletamine zolazepam butorphanol medetomidine reversed with atipamezole (TTDA) in seven cats. All data are presented as mean ± SEM. Significantly different from other treatment groups. Significantly different from the TTDA group. Significantly different from the TT group. Significantly different from the 5-minute value within the treatment group. ginning at 25 minutes and continuing through 75 minutes. There was no statistically significant difference in time from drug administration to recovery, sternal recumbency, or standing and walking between treatment groups (Table 2), although the TTDA group did show increased signs of central nervous system arousal (including more frequent head lifts and attempts to assume sternal recumbency) minutes after administration of atipamezole compared with the TTD group at the same time point (i.e., 6 minutes after initial TTD administration). These signs of arousal were not indicative of severe agitation. Algometric assessment revealed no difference in tolerance to pressure among treatment groups until 5 minutes after drug administration, at which point the TTD cats had significantly higher levels of analgesia (Figure 3). The TTD group had no significant changes in tolerance to pressure over the 8-minute duration. Starting 25 minutes after atipamezole injection (i.e., 5 minutes after TTD injection) and continuing for an additional 2 minutes (i.e., until 65 minutes after TTD injection), the level of anesthesia was lower in the TTDA group compared with the TTD group. The duration of lack of response to needle pricking on the front limb was similar between treatment groups. The duration of lack of response to needle pricking in the perineum was significantly shorter in the TTDA group beginning 5 minutes after atipamezole administration (Figure ). DISCUSSION This study demonstrated that both the TT and TTD combinations were effective for inducing and maintaining anesthesia and providing analgesia in cats. Cats in both groups as- 172
10 J. C. H. Ko, L. A. Abbo, A. B. Weil, B. M. Johnson, and M. Payton Analgesia Duration (min) Duration of Lack of Response in the Perineum Was Shorter in the TTDA Group Front Limb Perineum Anatomic Location TT TTD TTDA Figure 4. Analgesia evaluation via needle prick after IM administration of tiletamine zolazepam butorphanol (TT), tiletamine zolazepam butorphanol medetomidine (TTD), and tiletamine zolazepam butorphanol medetomidine reversed with atipamezole (TTDA) in seven cats. All data are presented as mean ± SEM. Significantly different from other treatment groups. sumed lateral recumbency and allowed orotracheal intubation to be easily accomplished within 5 minutes after drug administration. Occasional vomiting and myoclonic twitching responses have been reported cats following medetomidine administration, 9,12 1 but these responses were not observed in any cat during this study. The use of lidocaine to desensitize the larynx via either direct topical application or an aerosol spray has been reported to facilitate orotracheal intubation in cats. 15,16 Reportedly, aerosol application of lidocaine can induce a degree of tissue edema and cellular damage, and at least 9 seconds are needed for lidocaine application to be effective. 15,16 Our clinical observation indicates that many anesthesia providers do not wait this long before attempting intubation. As a result, the exact effect of lidocaine in facilitating intubation in cats is often questionable in clinical practice. In the current study, orotracheal intubation was achieved without the aid of topical lidocaine by using a semi-rigid plastic catheter as soon as the cats became laterally recumbent. No postanesthetic airway problems were observed in any cat. With the use of TT or TTD combinations, the key components to successful orotracheal intubation in these cats seem to be a semi-rigid plastic catheter and a laryngoscope. In a preliminary clinical study, we compared algometer readings in cats anesthetized with TTD for elective surgical procedures such as onychectomy, ovariohysterectomy, and castration. We found that an algometer reading on the front paws exceeding 85 kpa corresponded to analgesia sufficient for performing these surgical procedures; that is, cats that do not respond to an algometer-induced pressure of 85 kpa or higher would not respond to these surgical stimulations, whereas cats that had readings below 85 kpa would more likely react to surgical tissue manipulations. In the current study, the level of anesthesia analgesia as assessed by algometer was considered to be adequate (algometer readings above 85 kpa) during the first 25 minutes in the TT group, whereas the readings remained above 1, kpa for at least 65 minutes in the TTD group. Medetomidine reversal with atipamezole 2 minutes after TTD administration (TTDA group) resulted in a significant decrease in algometer readings 1 minutes later (i.e., 3 minutes after TTD administration); 2 minutes after atipamezole administration, the algometer reading was less than 85 kpa and remained so until the end of the experiment. This result indicates that medetomidine either directly contributed to or indirectly enhanced the analgesia induced by tiletamine and butorphanol in the TTD combination. Medetomidine provides α 2 receptor mediated analgesia in cats 17,18 and has 173
11 been shown to augment analgesia in injectable anesthetic combinations in other species. 18,19 In this study, it was hypothesized that the reversal of medetomidine by atipamezole in the TTDA group would shorten recovery time without affecting recovery quality. Our intention was to administer atipamezole 2 minutes after TTD administration to simulate a short surgical procedure and to see if recovery would be shortened after antagonism of medetomidine-induced sedation. Although treatment with atipamezole did not significantly shorten the time for cats to assume sternal recumbency or walking, these cats did show more signs of arousal, including earlier extubation, more head lifting, and increased attempts to assume sternal recumbency, between 6 and 11 minutes compared with the TTDtreated cats. The increased attempts to assume sternal recumbency in the TTDA group, based on the criteria used in this study, were considered to be indicative of a poor recovery. This was reflected in the overall significantly lower recovery score versus the TTD group. Atipamezole administration also reduced the intensity of the analgesia in the TTDA-treated cats, as discussed previously. Based on this information, we recommend that if a short (lasting less than 2 minutes), minimally painful procedure is performed on a cat anesthetized with a TTD combination, the medetomidine can be reversed with atipamezole so that the cat does not have a long duration of profound central nervous system depression. The lack of significant shortening of recovery duration after atipamezole administration may mainly be the result of residual anesthetic or sedative effects of tiletamine zolazepam and butorphanol. This explanation is supported by the similar recovery durations observed in the TTD- and TT-treated cats. In this study, a possible bias might be introduced in the analgesia, recovery, or sedation scoring because the observers were not blinded to which treatment each cat received. In the current study, blood pressure was well maintained in all three treatment groups, with the lowest MAP (83.3 ±.8 mm Hg) occurring 6 minutes after TTDA administration (i.e., minutes after atipamezole administration). The addition of medetomidine significantly increased DAP in the TTD-treated cats compared with the TT group. Medetomidine is known to increase systemic vascular resistance via its α 2 -adrenoceptor activity in cats, 2 which could partially explain the increase in DAP seen in this study. This is further supported by the observation that when atipamezole was admin- The quality of recovery score was significantly lower in the TTDA group than in the TTD group. istered to the TTD-treated cats (TTDA group), DAP significantly decreased from 17.7 ± 12.6 mm Hg to 58. ± 3. mm Hg and remained in this range until the end of the study. HRs were well maintained in cats in all three treatment groups, and an anticholinergic agent was not used. Tiletamine administration has been reported to increase HR in cats, 1 3 and HRs were significantly higher in cats in the TT groups throughout the study compared with cats in the other two groups. One possible explanation for the HRs observed in the TT-treated cats is a higher sympathetic tone induced by the higher dose of tiletamine in the TT group. Medetomidine has been demonstrated to significantly reduce heart rate in cats. 2 The lower HRs observed in the TTD- and TTDA-treated cats were likely a result of medetomidine- and butorphanol-mediated baroreflex and en- 17
12 J. C. H. Ko, L. A. Abbo, A. B. Weil, B. M. Johnson, and M. Payton hanced vagal activity offsetting a tiletamine-induced sympathomimetic effect. RRs decreased in all three treatment groups after drug administration. All three drug combinations had a significant effect on SpO 2, which significantly decreased from baseline after all treatments. The reduction of SpO 2 in the treated cats may be partially due to hypoventilation because partial pressure of arterial carbon dioxide was slightly higher than normal reported values. In discussing the effects of the drug combinations on RR and SpO 2 it should be noted that the sidestream capnometer used in the study drew a continuous sample of gas from the cat s endotracheal tube. A question was raised whether the sampling rate could be sufficiently high to possibly affect the fraction of inspired oxygen and therefore SpO 2. The sampling rate of the sidestream capnometer was 12 ± 2 ml/min based on the manufacturer s specification. While it is possible to have a negative effect on the fraction of inspired oxygen and SpO 2, we do not think a direct interference from the sidestream capnometer is likely because the SpO 2 was consistently above 92% in the latter part of the experiment and because the rate of gas sampling was constant. Because hypoxia occurred in all three treatment groups, it is advised that 1% oxygen be provided via face mask insufflation or endotracheal intubation. CONCLUSION In conclusion, a single IM injection of TT or TTD induced suitable anesthesia in healthy cats. The anesthetic duration of these combinations was approximately 7 to 9 minutes, with adequate surgical analgesic durations of 25 minutes for TT and 65 minutes for TTD. Cardiorespiratory changes were characterized by well-maintained blood pressure and mild respiratory depression with occasional hypoxia. Reversal of medetomidine with atipamezole was not entirely effective in shortening the total duration of recovery but did allow the cats to become alert somewhat earlier. ACKNOWLEDGMENT The authors thank Constance Nicklin for her technical assistance with this study. REFERENCES 1. Forsyth S: Administration of a low dose tiletamine-zolazepam combination to cats. N Z Vet J 3(3):11 13, Sendler K, Lendl C, Henke I, et al: Anesthesia in cats using tiletamine/zolazepam in minimal doses [in German]. Tierarztl Prax 22(3):286 29, Hellyer P, Muir WW, Hubbell JA, Sally J: Cardiorespiratory effects of the intravenous administration of tiletamine-zolazepam to cats. Vet Surg 17(2):15 11, Faggella AM, Aronsohn MG: Anesthetic techniques for neutering 6- to 1-week-old kittens. JAVMA 22(1):56 62, Lin HC, Benson GJ, Thurmon JC, et al: Influence of anesthetic regimens on the perioperative catecholamine response associated with onychectomy in cats. Am J Vet Res 5(1): , Ko JCH, Thurmon JC, Benson GJ, Tranquilli WJ: An alternative drug combination for use in declawing and castrating cats. Vet Med 88(11): , Williams LS, Levy JK, Robertson SA, et al: Use of the anesthetic combination of tiletamine, zolazepam, ketamine, and xylazine for neutering feral cats. JAVMA 22(1): , Cistola AM, Golder FJ, Centonze LA, et al: Anesthetic and physiologic effects of tiletamine, zolazepam, ketamine, and xylazine combination (TKX) in feral cats undergoing surgical sterilization. J Feline Med Surg 6(5):297 33, Verstegen J, Fargetton X, Ectors F: Medetomidine/ketamine anaesthesia in cats. Acta Vet Scand Suppl 85: , Bernhardt O, Schiffman EL, Look JO: Reliability and validity of a new fingertip-shaped pressure algometer for assessing pressure pain thresholds in the temporomandibular joint and masticatory muscles. J Orofac Pain 21(1):29 38, Varcoe-Cocks K, Sagar KN, Jeffcott LB, McGowan CM: Pressure algometry to quantify muscle pain in racehorses with suspected sacroiliac dysfunction. Equine Vet J 38(6): , Granholm M, McKusick BC, Westerholm FC, Aspe- 175
13 gren JC: Evaluation of the clinical efficacy and safety of dexmedetomidine or medetomidine in cats and their reversal with atipamezole. Vet Anaesth Analg 33():21 223, Cullen LK: Medetomidine sedation in dogs and cats: A review of its pharmacology, antagonism and dose. Br Vet J 152(5): , Vaha-Vahe T: The clinical efficacy of medetomidine. Acta Vet Scand Suppl 85: , Rex MA, Sutton RH, Reilly JS: The effects of lignocaine spray on the laryngeal mucosa of the cat. Anaesth Intensive Care 11(1):7 51, Dyson DH: Efficacy of lidocaine hydrochloride for laryngeal desensitization: A clinical comparison of techniques in the cat. JAVMA 192(9): , Ansah OB, Vainio O, Hellsten C, Raekallio M: Postoperative pain control in cats: Clinical trials with medetomidine and butorphanol. Vet Surg 31:99 13, Ansah OB, Raekallio M, Vainio O: Comparison of three doses of dexmedetomidine with medetomidine in cats following intramuscular administration. J Vet Pharm Ther 21:38 387, Grimm KA, Tranquilli WJ, Thurmon JC, Benson GJ: Duration of nonresponse to noxious simulation after intramuscular administration of butorphanol, medetomidine, or a butorphanol-medetomidine combination during isoflurane administration in dogs. Am J Vet Res 61(1):2 7, Lamont LA, Bulmer BJ, Grimm KA, et al: Cardiopulmonary evaluation of the use of medetomidine hydrochloride in cats. Am J Vet Res 62(11): ,
Comparison of Anesthetic and Cardiorespiratory Effects of Tiletamine Zolazepam Butorphanol and Tiletamine Zolazepam Butorphanol Medetomidine in Dogs*
J. C. H. Ko, M. Payton, A. B. Weil, T. Kitao, and T. Haydon Comparison of Anesthetic and Cardiorespiratory Effects of Tiletamine Zolazepam Butorphanol and Tiletamine Zolazepam Butorphanol Medetomidine
More informationDexmedetomidine and its Injectable Anesthetic-Pain Management Combinations
Back to Anesthesia/Pain Management Back to Table of Contents Front Page : Library : ACVC 2009 : Anesthesia/Pain Management : Dexmedetomidine Dexmedetomidine and its Injectable Anesthetic-Pain Management
More informationOxygenation in Medetomidine-Sedated Dogs with and without 100% Oxygen Insufflation
J. C. H. Ko, A. B. Weil, T. Kitao, M. E. Payton, and T. Inoue Oxygenation in Medetomidine-Sedated Dogs with and without 100% Oxygen Insufflation Jeff C. H. Ko, DVM, MS, DACVA a Ann B. Weil, DVM, MS, DACVA
More informationPakistan Veterinary Journal
RESEARCH ARTICLE Pakistan Veterinary Journal ISSN: 5-88 (PRINT), 74-7764 (ONLINE) Accessible at: www.pvj.com.pk A Comparison of Anesthetic and Cardiorespiratory Effects of Tiletamine-Zolazepam/Xylazine
More informationNorthwest A&F University, College of Veterinary Medicine, Yangling, China 3
ACTA VET. BRNO 2013, 82: 219 223; doi:10.2754/avb201382020219 Effects of tramadol with tiletamine/zolazepam-xylazine as anaesthesia in cats Lin Li 1a, Jing Dong 1a, Dezhang Lu 2, Sheng Jiang 3, Dongqi
More informationThis SOP presents commonly used anesthetic regimes in rabbits.
Comparative Medicine SOP #: 103. 01 Page: 1 of 7 Rabbit Anaesthesia The intent of this Standard Operating Procedure (SOP) is to describe commonly used methods to anesthetize rabbits at Comparative Medicine
More informationClinical applicability of dexmedetomidine for sedation, premedication and analgesia in cats 1 / 2007
1 / 2007 Clinical applicability of dexmedetomidine for sedation, premedication and analgesia in cats 1 5 Dexmedetomidine: a new 2-adrenoceptor agonist for modern multimodal anaesthesia in dogs and cats
More informationTop 5 Short Procedure Sedation Scenarios
Top 5 Short Procedure Scenarios Khursheed Mama, DVM, DACVAA Colorado State University can be used to facilitate management of aggressive animals, completion of minor procedures (eg, biopsy, laceration
More informationAnaesthetic effects of tiletamine-zolazepam-xylazine-tramadol combination in cats undergoing surgical sterilization
ACTA VET. BRNO 2015, 84: 181 185; doi:10.2754/avb201584020181 Anaesthetic effects of tiletamine-zolazepam-xylazine-tramadol combination in cats undergoing surgical sterilization Lin Li 1a, Jing Dong 1a,
More informationDISSOCIATIVE ANESTHESIA
DISSOCIATIVE ANESTHESIA Adarsh Kumar Dissociative anesthesia implies dissociation from the surrounding with only superficial sleep mediated by interruption of neuronal transmission from unconscious to
More informationPremedication with alpha-2 agonists procedures for monitoring anaesthetic
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Premedication with alpha-2 agonists procedures for monitoring anaesthetic Author : Lisa Angell, Chris Seymour Categories :
More informationReversal of Medetomidine-Ketamine Combination Anesthesia in Rabbits by Atipamezole
Exp. Anim. 53(5), 423 428, 2004 Reversal of Medetomidine-Ketamine Combination Anesthesia in Rabbits by Atipamezole Min Su KIM 1), Seong Mok JEONG 1), Jae Hak PARK 2), Tchi Chou NAM 1) and Kang Moon SEO
More informationAlfaxan. (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. TECHNICAL NOTES DESCRIPTION INDICATIONS
Alfaxan (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. NADA 141-342, Approved by FDA ALFAXAN (Schedule: C-IV) (alfaxalone 10 mg/ml) Intravenous injectable anesthetic
More informationA comparison of three combinations of injectable anesthetics in miniature donkeys
Veterinary Anaesthesia and Analgesia, 2002, 29, 36^42 RESEARCH PAPER A comparison of three combinations of injectable anesthetics in miniature donkeys Nora S Matthews DVM, Dip ACVA, Tex S Taylor DVM, Dip
More informationComparison of anesthesia with a morphine lidocaine ketamine infusion or a morphine lidocaine epidural on time to extubation in dogs
Veterinary Anaesthesia and Analgesia, 2016, 43, 86 90 doi:10.1111/vaa.12273 SHORT COMMUNICATION Comparison of anesthesia with a morphine lidocaine ketamine infusion or a morphine lidocaine epidural on
More informationBehavioral responses following eight anesthetic induction protocols in horses
Veterinary Anaesthesia and Analgesia, 2002, 29, 207^211 RESEARCH PAPER Behavioral responses following eight anesthetic induction protocols in horses Ann E Wagner DVM, MS, Diplomate ACVP, ACVA, Khursheed
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Domitor 1 solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Medetomidine hydrochloride (equivalent
More informationMetacam. The Only NSAID Approved for Cats in the US. John G. Pantalo, VMD Professional Services Veterinarian. Think easy. Think cat. Think METACAM.
Metacam The Only NSAID Approved for Cats in the US John G. Pantalo, VMD Professional Services Veterinarian Think easy. Think cat. Think METACAM. Today s Agenda New pain management guidelines for cats Only
More informationGUIDELINES FOR ANESTHESIA AND FORMULARIES
GUIDELINES FOR ANESTHESIA AND FORMULARIES Anesthesia is the act of rendering the animal senseless to pain or discomfort and is required for surgical and other procedures. Criteria for choosing an anesthetic
More informationTELAZOL (tiletamine and zolazepam for injection) IV Induction Claim FAQs 1, 2
TELAZOL (tiletamine and zolazepam for injection) IV Induction Claim FAQs 1, 2 1) Q: What is TELAZOL? A: TELAZOL (tiletamine and zolazepam for injection) is a nonnarcotic, nonbarbiturate, injectable anesthetic
More informationT u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods
T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods Abbreviations: General Considerations IV = intravenous SC = subcutaneous
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Narketan-10 100 mg/ml Solution for Injection. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance
More informationthe same safe, reliable sedation and analgesia as DEXDOMITOR. specifically made for cats that weigh 7 lb or less.
feline dosing chart DEXDOMITOR 0.1 mg/ml (dexmedetomidine) Sedation/analgesia in cats Feline 40 mcg/kg IM lb kg ml 2 4 1 2 4.1 7 2.1 3 0.5 1.0 For higher weight ranges, use DEXDOMITOR (dexmedetomidine),
More informationDepartment of Laboratory Animal Resources. Veterinary Recommendations for Anesthesia and Analgesia
Department of Laboratory Animal Resources Guideline Veterinary Recommendations for Anesthesia and Analgesia A. PRINCIPLES OF ANESTHESIA AND ANALGESIA 1. The proper anesthetic and analgesic agents must
More informationGastroduodenoscopy is a procedure commonly used. Evaluation of the effects of premedication on gastroduodenoscopy in cats
Evaluation of the effects of premedication on gastroduodenoscopy in cats Alison A. Smith, DVM; Lysa P. Posner, DVM; Richard E. Goldstein, DVM, DACVIM; John W. Ludders, DVM, DACVA; Hollis N. Erb, DVM, PhD;
More informationComparison of 3 Total Intravenous Anesthetic Infusion Combinations in Adult Horses
Comparison of 3 Total Intravenous Anesthetic Infusion Combinations in Adult Horses Courtney L. Baetge, DVM Nora S. Matthews, DVM, Dip. ACVA Gwendolyn L. Carroll, DVM, Dip. ACVA Texas A&M University College
More informationPreanesthesia in dogs Dog Weight. Sedation/analgesia in dogs Dog Weight. Sedation/analgesia and preanesthesia in cats
Package Insert NADA 141-267, Approved by FDA. (dexmedetomidine hydrochloride) Sterile Injectable Solution 0.5 mg/ml Intramuscular and Intravenous use in Dogs Intramuscular use in Cats Sedative, Analgesic,
More informationInduction of a Transient Chemically Induced Lameness in the Sow. Detection Using a Prototype Embedded Micro-computerbased Force Plate System
Animal Industry Report AS 657 ASL R2629 11 Induction of a Transient Chemically Induced Lameness in the Sow. Detection Using a Prototype Embedded Micro-computerbased Force Plate System Anna K. Johnson Kenneth
More informationDexmedetomidine. Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai. History
Dexmedetomidine Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai Dexmedetomidine is the most recently released IV anesthetic. It is a highly selective α 2 -adrenergic agonist
More informationThese notes discuss these challenges and provides updates on how to address these challenges.
Anesthesia and Pain Management For Spay/ Neuter (TNR Clinics) Mehnaz Chumkee Aziz, DVM Resident, Koret Shelter Medicine Program, University of California, Davis, CA, USA INTRODUCTION The primary goal of
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NOSEDORM 5 mg/ml Solution for injection for dogs and cats [DE, ES, FR, PT] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each
More informationPain Management in Racing Greyhounds
Pain Management in Racing Greyhounds Pain Pain is a syndrome consisting of multiple organ system responses, and if left untreated will contribute to patient morbidity and mortality. Greyhounds incur a
More informationDay 90 Labelling, PL LABELLING AND PACKAGE LEAFLET
LABELLING AND PACKAGE LEAFLET A. LABELLING PARTICULARS TO APPEAR ON THE OUTER PACKAGE : Carton 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Alvegesic vet. 10 mg/ml Solution for injection for Horses, Dogs
More informationCanine Dosing Chart DEXDOMITOR
Canine Dosing Chart DEXDOMITOR (dexmedetomidine) -.5 mg/ Preanesthesia in dogs Sedation/analgesia in dogs Canine Weight 5 IM 375 IM 375 IV 5 IM lb kg kg kg kg kg 4.4 7 3.4.4 8.. 8.. 4.5 7. 3. 4 8.3.5 5.5
More informationHealth Products Regulatory Authority
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Ketamidor 100 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Active substance: Ketamine (as hydrochloride) Excipient:
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Xylacare 2% w/v Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Qualitative composition
More informationSTANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA
STANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA 1. PURPOSE This Standard Operating Procedure (SOP) describes methods for anesthetizing rats. 2. RESPONSIBILITY Principal Investigators (PIs) and their research
More informationA study to evaluate buprenorphine at 40 lg kg )1 compared to 20 lg kg )1 as a post-operative analgesic in the dog
Veterinary Anaesthesia and Analgesia, 211, 38, 584 593 doi:1.1111/j.1467-2995.211.656.x RESEARCH PAPER A study to evaluate buprenorphine at 4 lg kg )1 compared to 2 lg kg )1 as a post-operative analgesic
More informationProceedings of the International Congress of the Italian Association of Companion Animal Veterinarians
www.ivis.org Proceedings of the International Congress of the Italian Association of Companion Animal Veterinarians June 8-10, 2012 - Rimini, Italy Next SCIVAC Congress: Mar. 8-10, 2013 Pisa, Italy SCIVAC
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ANESKETIN 100 mg/ml solution for injection for dogs, cats and horses Belgium: NIMATEK 100 mg/ml solution for injection for
More informationCandidate Name: PRACTICAL Exercise Medications & Injections
PRACTICAL Exercise Medications & Injections VERY IMPORTANT Method: In groups - staggered - PLEASE WAIT YOUR TURN / STAND BACK IF ASKED Do bookwork - work out dosages - 1a / 2a / 3a Got to Medications Table
More informationSedative and antinociceptive effects of dexmedetomidine and buprenorphine after oral transmucosal or intramuscular administration in cats
Veterinary Anaesthesia and Analgesia, 2014, 41, 90 96 doi:10.1111/vaa.12076 RESEARCH PAPER Sedative and antinociceptive effects of dexmedetomidine and buprenorphine after oral transmucosal or intramuscular
More informationCardiovascular, respiratory, electrolyte and acid base balance during continuous dexmedetomidine infusion in anesthetized dogs
Veterinary Anaesthesia and Analgesia, 2013, 40, 464 471 doi:10.1111/vaa.12036 RESEARCH PAPER Cardiovascular, respiratory, electrolyte and acid base balance during continuous dexmedetomidine infusion in
More informationThe cardiovascular and respiratory effects of medetomidine and thiopentone anaesthesia in dogs breathing at an altitude of 1486 m
Article Artikel The cardiovascular and respiratory effects of medetomidine and thiopentone anaesthesia in dogs breathing at an altitude of 1486 m K E Joubert a and R Lobetti b ABSTRACT The purpose of this
More informationEXOTIC SMALL MAMMAL ANESTHETIC TECHNIQUES
EXOTIC SMALL MAMMAL ANESTHETIC TECHNIQUES Jody Nugent-Deal, RVT, VTS (Anesthesia) and (Clinical Practice Exotic Companion Animal) Veterinary Medical Teaching Hospital University of California, Davis, CA
More informationComparison of three anaesthetic protocols in Bennett s wallabies (Macropus rufogriseus)
Veterinary Anaesthesia and Analgesia, 2010, 37, 207 214 doi:10.1111/j.1467-2995.2009.00523.x RESEARCH PAPER Comparison of three anaesthetic protocols in Bennett s wallabies (Macropus rufogriseus) Tim Bouts*,
More informationTiletamine-Zolazepam anesthesia in horses : repeated dose versus continuous infusion
Tiletamine-Zolazepam anesthesia in horses : repeated dose versus continuous infusion M.A. LÔPEZ, J. JIMÉNEZ, M.F. MARTÌN, J.M. USÓN, E.M. PÉREZ and L.J. EZQUERRA* Hospital Clínico Veterinario, Universidad
More informationUNIVERSITY OF PITTSBURGH Institutional Animal Care and Use Committee
UNIVERSITY OF PITTSBURGH Institutional Animal Care and Use Committee Policy: Surgical Guidelines EFFECTIVE ISSUE DATE: 2/21/2005 REVISION DATE(s): 2/14/15; 3/19/2018 SCOPE To describe guidelines and considerations
More informationCO Oguntoye* & BO Oke
RESEARCH ARTICLE Sokoto Journal of Veterinary Sciences (P-ISSN 1595-093X/ E-ISSN 2315-6201) Oguntoye & Oke /Sokoto Journal of Veterinary Sciences (2014) 12(3): 21-25 http://dx.doi.org/10.4314/sokjvs.v12i3.4
More informationA Clinical Study of Dexmedetomidine under Combined Spinal Epidural Anaesthesia at a Tertiary Care Hospital
Original Research A Clinical Study of Dexmedetomidine under Combined Spinal Epidural Anaesthesia at a Tertiary Care Hospital Kamala GR 1, Leela GR 2 1 Assistant Professor, Department of Anaesthesiology,
More informationANESTHESIA, CHEMICAL RESTRAINT AND PAIN MANAGEMENT IN SNAKES (SERPENTES) A REVIEW. Seven Mustafa, Nadya Zlateva
TRADITION AND MODERNITY IN VETERINARY MEDICINE, 2018, vol. 3, No 1(4): 37 44 ANESTHESIA, CHEMICAL RESTRAINT AND PAIN MANAGEMENT IN SNAKES (SERPENTES) A REVIEW Seven Mustafa, Nadya Zlateva University of
More informationCorresponding author: V. Dua, Department of Anaesthesia, BJ Wadia Hospital for Children, Parel, Mumbai, India.
Comparative evaluation of dexmedetomidine as a premedication given intranasally vs orally in children between 1 to 8 years of age undergoing minor surgical procedures V. Dua, P. Sawant, P. Bhadlikar Department
More informationProcedure # IBT IACUC Approval: December 11, 2017
IACUC Procedure: Anesthetics and Analgesics Procedure # IBT-222.04 IACUC Approval: December 11, 2017 Purpose: The purpose is to define the anesthetics and analgesics that may be used in mice and rats.
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Anaestamine 100 mg/ml solution for injection Aniketam, 100 mg/ml solution for injection (EE/LT/LV) Aniketam vet., 100 mg/ml
More informationAnesthetic regimens for mice, rats and guinea pigs
Comparative Medicine SOP #: 101. 01 Page: 1 of 10 Anesthetic regimens for mice, rats and guinea pigs The intent of the Standard Operating Procedure (SOP) is to describe commonly used methods to anaesthetize
More informationSTANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA
STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA 1. PURPOSE This Standard Operating Procedure (SOP) describes methods for anesthetizing mice. 2. RESPONSIBILITY Principal Investigators (PIs) and their
More informationA New Advancement in Anesthesia. Your clear choice for induction.
A New Advancement in Anesthesia Your clear choice for induction. By Kirby Pasloske When using Alfaxan, patients should be continuously monitored, and facilities for maintenance of a patent airway, artificial
More informationNon-invasive, mildly to moderately painful, procedures and examinations which require restraint, sedation and analgesia in dogs and cats.
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Sedadex 0.1 mg/ml solution for injection for dogs and cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Active substance: Dexmedetomidine hydrochloride
More informationProceedings of the International Congress of the Italian Association of Companion Animal Veterinarians
www.ivis.org Proceedings of the International Congress of the Italian Association of Companion Animal Veterinarians June 8-10, 2012 - Rimini, Italy Next SCIVAC Congress: Mar. 8-10, 2013 Pisa, Italy SCIVAC
More informationJournal of Zoo and Wildlife Medicine 33(2): , 2002 Copyright 2002 by American Association of Zoo Veterinarians
Journal of Zoo and Wildlife Medicine 33(2): 1, 02 Copyright 02 by American Association of Zoo Veterinarians CARDIORESPIRATORY EFFECTS OF MEDETOMIDINE BUTORPHANOL, MEDETOMIDINE BUTORPHANOL DIAZEPAM, AND
More information1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
PACKAGE LEAFLET FOR: Dormilan solution for injection for dogs and cats [FR] Dormilan 1 mg/ml solution for injection for dogs and cats [DE, PT, UK] Reanest 1 mg/ml solution for injection for dogs and cats
More informationVol. 24, No. 5 May Animal Care Center of Sonoma County Sonoma, California Marcia L. Aubin, DVM, MS*
Vol. 24, No. 5 May 2002 411 CE Article #5 (1.5 contact hours) Refereed Peer Review Comments? Questions? Email: compendium@medimedia.com Web: VetLearn.com Fax: 800-556-3288 KEY FACTS Achieving adequate
More informationShort duration anaesthesia with medetomidine and ketamine in cynomolgus monkeys
Short duration anaesthesia with medetomidine a ketamine in cynomolgus monkeys S. S. Young, A. M. Schilling, S. Skeans & G. Ritacco Department of Allergy, Schering-Plough Research Institute, Kenilworth,
More informationWhat dose of methadone should I use?
What dose of methadone should I use? Professor Derek Flaherty BVMS, DVA, DipECVAA, MRCA, MRCVS RCVS and European Specialist in Veterinary Anaesthesia SPC dose rates for Comfortan dogs: 0.5-1.0 mg/kg SC,
More informationDOI /yydb medetomidine a review of clinical applications J. Curr Opin Anaesthesiol
1573 medetomidine a review of clinical applications J. Curr Opin Anaesthesiol 2008 21 4 457-461. 6 DAHMANI S PARIS A JANNIER V et al. Dexmedetom- 2. α 2 idine increases hippocampal phosphorylated extracellular
More informationCLINICAL ESSENTIAL HUDDLE CARD. All associates must comply with their state practice acts.
CLINICAL ESSENTIAL HUDDLE CARD All associates must comply with their state practice acts. QUESTIONS FOR DISCUSSION Where can you find information about your state practice acts? If you are unclear of what
More informationPerioperative Care of Swine
Swine are widely used in protocols that involve anesthesia and invasive surgical procedures. In order to ensure proper recovery of animals, preoperative, intraoperative and postoperative techniques specific
More informationEarn a rebate on pioneering brands you trust.
SPRING INTO SPRING PROMOTION Earn a rebate on pioneering brands you trust. For over 20 years and with your help, Zoetis has changed the veterinary world with the shared vision to provide comfort through
More informationMouse Formulary. The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.
Mouse Formulary The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.): Intraperitoneal (IP) doses should not exceed 80 ml/kg
More informationCAT AND DOG ANESTHESIA
Document: ACUP104.03 Issue Date: 21 SEP 17; Effective Date: 21 SEP 17 Authorization: Dr. N. Place, IACUC Chair Author: E. Silvela (Revision) CAT AND DOG ANESTHESIA 1. PURPOSE 1.1. The purpose of this Animal
More informationOriginal Article INTRODUCTION. Abstract
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2016/305 Comparison between 0.5 µg/kg Dexmedetomidine with 0.5% Lignocaine and 0.5% Lignocaine Alone in Intravenous for
More informationBUTORPHANOL AND AZAPERONE AS A SAFE ALTERNATIVE FOR REPEATED CHEMICAL RESTRAINT IN CAPTIVE WHITE RHINOCEROS (CERATOTHERIUM SIMUM)
Journal of Zoo and Wildlife Medicine 3(2): 96 200, 2000 Copyright 2000 by American Association of Zoo Veterinarians BUTORPHANOL AND AZAPERONE AS A SAFE ALTERNATIVE FOR REPEATED CHEMICAL RESTRAINT IN CAPTIVE
More information6/10/2015. Multi Purpose Canine (MPC) Restraint and Physical Examination PFN: Terminal Learning Objective. Hours: Instructor:
Multi Purpose Canine (MPC) Restraint and Physical Examination PFN: Hours: Instructor: Slide 1 Slide 2 Terminal Learning Objective Action: Communicate knowledge of Multi Purpose Canine (MPC) restraint and
More informationUSE OF MEDETOMIDINE HYDROCHLORIDE AS SEDATIVE IN CATTLE CALVES
ISSN 1023-1072 Pak. J. Agri., Agril. Engg., Vet. Sci., 2010, 26 (2): 87-99 USE OF MEDETOMIDINE HYDROCHLORIDE AS SEDATIVE IN CATTLE CALVES 11 A. B. Kalhoro, M. Tariq, A. B. Kachiwal, R. Rind, D. H. Kalhoro
More informationAnesthesia & analgesia in birds
Anesthesia and analgesia in birds Yvonne R.A. van Zeeland, DVM, PhD, MVR, Dip. ECZM (avian) Division of Zoological Medicine, Utrecht University Anesthesia & analgesia in birds Yvonne van Zeeland DVM, MVR,
More informationAnaesthesia and Analgesia of fish
Anaesthesia and Analgesia of fish Dr Stewart Fielder Port Stephens Fisheries Institute Marine fish production and enhancement Plan of talk Who uses anaesthetics for fish Why anaesthetics are used When
More informationtake pain out of the pet s experience.
take pain out of the pet s experience. The analgesic properties of DEXDOMITOR (dexmedetomidine) give dogs and cats respite from mild or moderate pain associated with a procedure. By reducing discomfort,
More informationPOLICY ON ASEPTIC RECOVERY SURGERY ON USDA REGULATED NONRODENT SPECIES Adopted by the University Committee on Animal Resources October 15, 2014
POLICY ON ASEPTIC RECOVERY SURGERY ON USDA REGULATED NONRODENT SPECIES Adopted by the University Committee on Animal Resources October 15, 2014 The U.S.D.A Animal Welfare Act (9 CFR) requires use of aseptic
More informationPeriod of study: 12 Nov 2002 to 08 Apr 2004 (first subject s first visit to last subject s last visit)
Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website and is provided for patients and healthcare professionals to increase the transparency of Bayer's
More information1/30/2017. Introduction Sedation/anesthesia considerations & concerns Bovine, Small ruminants, swine south camelids?
Introduction Sedation/anesthesia considerations & concerns Bovine, Small ruminants, swine south camelids? Sedative and anesthetic drugs Sedation/Anesthetic protocols Dr. P. Queiroz-Williams Veterinary
More informationTransnasal administration of a combination of dexmedetomidine, midazolam and butorphanol produces deep sedation in New Zealand White rabbits
Veterinary Anaesthesia and Analgesia, 2016, 43, 209 214 doi:10.1111/vaa.12278 SHORT COMMUNICATION Transnasal administration of a combination of dexmedetomidine, midazolam and butorphanol produces deep
More informationCase Reports. Keywords: Cheetah; Epidural Anaesthesia; Isoflurane; Sparing Effect; Analgesia.
Combined Epidural Lidocaine and Medetomidine-Ketamine- Isoflurane Anaesthesia for Management of Femoral Fracture in a Cheetah (Acinonyx jubatus), 1 * Mogoa, E.M., 1 Kimeli, P., 1 Muasya, D.W., 1 Kipyegon,
More informationThe UCD community has made this article openly available. Please share how this access benefits you. Your story matters!
Provided by the author(s) and University College Dublin Library in accordance with publisher policies., Please cite the published version when available. Title The use of epidurals in cattle Authors(s)
More informationAnesthesia in an English Bulldog
Anesthesia in an English Bulldog Jennifer E. Carter, DVM, DACVAA, CVPP University of Melbourne THE CASE Hugo, a 7-year-old neutered male English bulldog, is presented for dental cleaning with possible
More informationLARC FORMULARY ANESTHESIA AND ANALGESIA IN LABORATORY ANIMALS
Research Office Laboratory Animal Resources Center Subject: LARC FORMULARY Date: IACUC Approved: 08/24/2011 Page 1 of 29 LARC FORMULARY ANESTHESIA AND ANALGESIA IN LABORATORY ANIMALS Page Contents 1. I.
More informationGuide to Veterinary Surgery If you are like most people, you want to know what you
Guide to Veterinary Surgery If you are like most people, you want to know what you are paying for and why things cost what they do. You will find that veterinary providers are all different, and you may
More information! The best anaesthesia is the one you have experience with!
WILDLIFE CHEMICAL CAPTURE AND ANAESTHESIA II! C. Walzer! Research Institute of Wildlife Ecology! University of Veterinary Medicine, Vienna, Austria! Wisdom 1! The best anaesthesia is the one you have experience
More informationPOST-OPERATIVE ANALGESIA AND FORMULARIES
POST-OPERATIVE ANALGESIA AND FORMULARIES An integral component of any animal protocol is the prevention or alleviation of pain or distress, such as that associated with surgical and other procedures. Pain
More informationPerioperative Pain Management in Veterinary Patients
Perioperative Pain Management in Veterinary Patients Doris H. Dyson, DVM, DVSc KEYWORDS Analgesia Surgical pain Dog Cat As veterinarians in the twenty-first century, we have an ethical responsibility to
More informationASMIC 2016 DEXMEDETOMIDINE IN THE INTENSIVE CARE UNIT DR KHOO TIEN MENG
ASMIC 2016 DEXMEDETOMIDINE IN THE INTENSIVE CARE UNIT DR KHOO TIEN MENG PREAMBLE : EVOLUTION OF SEDATION IN THE ICU 1980s : ICU sedation largely extension of GA No standard approach, highly variable Deep
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DEXDOMITOR 0.1 mg/ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Excipients:
More informationPROTOCOL FOR ANIMAL USE AND CARE
PROTOCOL FOR ANIMAL USE AND CARE Score 1: Score 2: Total: 1. Contacts Primary Investigator Alternate contact Name Sandra Weisker Name Email sweisker@ucdavis.edu Email Dept Animal Science Dept Telephone
More informationIs Atipamezole better than Yohimbine for reversal of Xylazine in male C57BL/6 mice anesthetized with Ketamine/Xylazine?
Is Atipamezole better than Yohimbine for reversal of Xylazine in male C57BL/6 mice anesthetized with Ketamine/Xylazine? Chris Janssen DVM Kara Kracinovsky ALAT Joe Newsome DVM, DACLAM University of Pittsburgh
More informationAlfaxalone induction dose following administration of medetomidine and butorphanol in the dog
Veterinary Anaesthesia and Analgesia, 2010, 37, 7 13 doi:10.1111/j.1467-2995.2009.00503.x RESEARCH PAPER Alfaxalone induction dose following administration of medetomidine and butorphanol in the dog Kieren
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Dormilan solution for injection for dogs and cats [FR] Dormilan 1 mg/ml solution for injection for dogs and cats [DE, ES,
More informationArticle Artikel. M Bush a*, J P Raath b, L G Phillips c and W Lance d
Article Artikel Immobilisation of impala (Aepyceros melampus) with a ketamine hydrochloride/medetomidine hydrochloride combination, and reversal with atipamezole hydrochloride M Bush a*, J P Raath b, L
More informationStudy between clonidine and dexmedetomidine in attenuation of pressor response during endotracheal intubation
Original Research Article Study between clonidine and dexmedetomidine in attenuation of pressor response during endotracheal intubation K. Selvarju 1, Kondreddi Narayana Prasad 2*, Ajay Kumar Reddy Bobba
More informationPropofol vs Dexmedetomidine
Propofol vs Dexmedetomidine A highlight of similarities & differences Lama Nazer, PharmD, BCPS Critical Care Clinical Pharmacy Specialist King Hussein Cancer Center Outline Highlight similarities and differences
More informationHemodynamic effects of dexmedetomidine-- fentanyl vs. nalbuphine--propofol in plastic surgery
Hemodynamic effects of dexmedetomidine-- fentanyl vs. nalbuphine--propofol in plastic surgery Juan F. De la Mora-González *, José A. Robles-Cervantes 2,4, José M. Mora-Martínez 3, Francisco Barba-Alvarez
More informationVeterinary Anaesthesia and Analgesia, 2015, 42,
Veterinary Anaesthesia and Analgesia, 2015, 42, 350 359 doi:10.1111/vaa.12218 RESEARCH PAPER A comparison of cardiopulmonary function, recovery quality, and total dosages required for induction and total
More information